Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human ...

Newco Brink Therapeutics SAS is poised to work on the next chapter in genome editing after raising €3.5 million (US$4 million) in seed funding to discover and develop programmable recombinase enzymes.

CASGEVY became the world's first genome editing therapy to receive marketing authorization, beginning with the United Kingdom ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

A US bio firm has announced the "rebirth" of an extinct carnivore called the dire wolf by using genome editing technology.

The North America CRISPR gene editing market is poised for substantial growth, with projections indicating a robust annual expansion of 24.4% throughout the forecast period. By 2031, it is anticipated ...

The Workshop on Genome Editing Tool Developments and Clinical Applications (#HKCRISPR25) was successfully held at the Hong ...

The Birbal Sahni Institute of Palaeosciences (BSIP) in the city, in collaboration with the Zoological Survey of India (ZSI), ...

Editas Medicine, Inc.’s EDIT share price has dipped by 5.16%, which has investors questioning if this is right time to buy.

In a major breakthrough, a team at the Center for Advanced Bioenergy and Bioproducts Innovation (CABBI) found a new way to acccelerate plant bioengineering using robots. Researchers deployed a ...

ToolGen commences legal action in UK court over Vertex's genome editing therapy, CASGEVY ®Seeks to expand licensing of its proprietary CRISPR RNP technologySEOUL, South Korea, April 21, 2025 /PRNewswi ...